Skip to main content

Month: August 2021

Atlanticus Announces Approval of Quarterly Preferred Stock Dividend

ATLANTA, Aug. 26, 2021 (GLOBE NEWSWIRE) — Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus,” “the Company”, “we,” “our” or “us”), a technology-enabled financial services company that assists financial institutions in offering credit to millions of everyday Americans, today announced that its Board of Directors approved a quarterly dividend of $0.49774 per share to Series B Cumulative Perpetual Preferred stockholders. The cash dividend will be paid on or about September 15, 2021 to holders of record of Atlanticus’ Series B Cumulative Perpetual Preferred Stock on the close of business on September 3, 2021. About Atlanticus Holdings Corporation Empowering Better Financial Outcomes for Everyday Americans Founded in 1996, our business utilizes proprietary analytics and a flexible technology platform to enable financial institutions...

Continue reading

HP Inc. Reports Fiscal 2021 Third Quarter Results

PALO ALTO, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) — HP (NYSE: HPQ)Third quarter GAAP diluted net earnings per share (“EPS”) of $0.92, above the previously provided outlook of $0.77 to $0.81 per share Third quarter non-GAAP diluted net EPS of $1.00, above the previously provided outlook of $0.81 to $0.85 per share Third quarter net revenue of $15.3 billion, up 7.0% from the prior-year period Third quarter net cash provided by operating activities of $1.1 billion, free cash flow of $1.0 billion Third quarter returned $1.7 billion to shareholders in the form of share repurchases and dividendsHP Inc.’s fiscal 2021 third quarter financial performance          Q3 FY21   Q3 FY20   Y/Y  GAAP net revenue ($B) $ 15.3   $ 14.3   7.0%  GAAP operating margin   9.0%     5.4%   3.6 pts  GAAP net earnings ($B) $ 1.1   $ 0.7   51%  GAAP...

Continue reading

Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement

Shares of Aadi to commence trading on the Nasdaq Capital Market on August 27, 2021 under ticker symbol “AADI” Concurrent $155 million PIPE financing is backed by leading life science investors led by Acuta Capital Partners and KVP Capital and included Avoro Capital Advisors; Avoro Ventures; Venrock Healthcare Capital Partners; BVF Partners, L.P.; Vivo Capital; Alta Bioequities, L.P.; Rock Springs Capital; RTW Investments, LP; Acorn Bioventures; and Serrado Capital LLC Cash and cash equivalents of approximately $170 million as of merger closeLOS ANGELES, Aug. 26, 2021 (GLOBE NEWSWIRE) — Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced the closing of its previously announced...

Continue reading

Navios Maritime Partners L.P. Announces a Merger with Navios Maritime Acquisition Corporation

Navios Maritime Acquisition Corporation Ship Mortgage Notes being Redeemed Conference Call & Webcast: Tuesday, August 31, 2021 at 8:30 am ET MONACO, Aug. 26, 2021 (GLOBE NEWSWIRE) — Navios Maritime Partners L.P. (“Navios Partners”) (NYSE: NMM), an international owner and operator of dry cargo vessels, and Navios Maritime Acquisition Corp. (“Navios Acquisition”) (NYSE:NNA), an international owner and operator of tanker vessels, announced today a definitive transaction agreement providing for a combination of Navios Partners and Navios Acquisition in a transaction in which shareholders of Navios Acquisition will receive 0.1275 of a common unit of Navios Partners for each outstanding common share of Navios Acquisition. All of Navios Acquisition’s outstanding 8.125% First Priority Ship Mortgage Notes, due on November 15, 2021...

Continue reading

Humacyte Announces Successful Closing of Business Combination with Alpha Healthcare Acquisition Corp.

Kathleen SebeliusChair of Humacyte’s Board of DirectorsDr. Laura NiklasonFounder, President & CEO of HumacyteRajiv ShuklaCEO of Alpha Healthcare Acquisition Corp.Humacyte raises $245M gross proceeds Combined company is expected to begin trading on the Nasdaq Global Select Market® under “HUMA” and “HUMAW” on August 27, 2021 Company well-positioned to deliver on promise of regenerative tissue HAV technology for initial indications in vascular trauma, AV access and peripheral arterial disease Combined company will be led by Laura Niklason, M.D., Ph.D., Founder, President & CEO, and current executive team Kathleen Sebelius appointed Chair of the Board of Directors Humacyte to commemorate milestone by ringing Nasdaq closing bell on Monday, August 30, 2021DURHAM, N.C., Aug....

Continue reading

Ollie’s Bargain Outlet Holdings, Inc. Reports Second Quarter Fiscal 2021 Financial Results

~ Company Achieves 2-Year Comparable Store Sales Stack of +15.3% ~~ Strong Earnings Flow-Through, Resulting in Diluted EPS of $0.52 ~ HARRISBURG, Pa., Aug. 26, 2021 (GLOBE NEWSWIRE) — Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) (the “Company”) today reported financial results for the second quarter ended July 31, 2021. “We are very pleased with our results for the second quarter as we delivered comparable store sales growth of 15.3% on a two-year stack basis, well ahead of our long-term growth algorithm, and adjusted EBITDA growth of 44% as compared to 2019,” stated John Swygert, President and Chief Executive Officer.  “Our performance reflects the strength of our business model as well as outstanding execution by our team, particularly with the headwinds of heightened supply chain challenges.” Second Quarter Summary:...

Continue reading

Rapid Micro Biosystems Reports Second Quarter 2021 Financial Results and Provides Business Update and Full Year 2021 Outlook

Reports second quarter 2021 commercial revenue of $5.7 million, representing 135% year-over-year growth Issues full-year 2021 outlook for commercial revenue of at least $24.0 million, representing at least 70% year-over-year growth LOWELL, Mass, Aug. 26, 2021 (GLOBE NEWSWIRE) —  Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the second quarter ended June 30, 2021 and provided a business update and full year 2021 outlook. Financial Highlights and Business UpdateGenerated commercial revenue (combined product and service revenue) of $5.7 million for the second quarter of 2021, representing 135%...

Continue reading

Peloton Interactive, Inc. Reports Fourth Quarter and Full-Year Fiscal 2021 Financial Results

NEW YORK, Aug. 26, 2021 (GLOBE NEWSWIRE) — Peloton Interactive, Inc. (Nasdaq: PTON) has announced its financial results for fourth quarter and full-year fiscal 2021. Please visit the Peloton investor relations website https://investor.onepeloton.com/financial-information/quarterly-results to view the fourth quarter and full-year fiscal 2021 shareholder letter. Today the company will host a live audio webcast of its conference call to discuss the results at 5:00 p.m. ET. Additional Call Details: What: Peloton Fourth Quarter and Full-Year 2021 Earnings Conference Call When: Thursday, August 26, 2021 Time: 5:00 p.m. ET Live Call: 1-877-667-0469 (US) or 1-346-406-0807 (international), Conference ID: 3586993 Webcast: https://investor.onepeloton.com/financial-information/quarterly-results The archived webcast of the conference call will...

Continue reading

Snap One Reports Fiscal Second Quarter 2021 Results

Strong Operating Results Reflect Robust Demand for Smart Living Solutions, Leading to 34% Increase in Net Sales, 67% Decrease in Net Loss, and 20% Increase in Adjusted EBITDA First Half of the Year Highlighted by Strategic Acquisition of Access Networks, Expansion of Omni-Channel Presence into Five New Domestic Markets, Corporate Rebranding, and Successful Initial Public Offering and Public Listing CHARLOTTE, N.C., Aug. 26, 2021 (GLOBE NEWSWIRE) — Snap One Holdings Corp. (NASDAQ: SNPO) (“Snap One,” the “Company,” “we” or “our”), a provider of smart living products, services, and software to professional integrators, reported financial results for the fiscal second quarter ended June 25, 2021. Recent Operational HighlightsJuly: Completed successful initial public offering of 15,020,812 primary shares of common stock at $18.00...

Continue reading

Lantronix Reports Record Results for Fourth Quarter and Fiscal 2021

Record Fourth Quarter Net Revenue of $20.6 Million, Up 19% Year Over Year Record Fiscal Year 2021 Net Revenue of $71.5 Million, Up 19% Year Over Year GAAP Gross Margins of 48.8% Improved 370 Basis Points Sequentially From 45.1% and Improved 1,110 Basis Points from 37.7% in the Year Ago Fourth Quarter, Reflecting Improved Product Mix Fourth Quarter GAAP EPS Improved to ($0.04) per Share vs. ($0.06) in the Prior Year Fourth Quarter Non-GAAP EPS Increased to $0.06 per share vs. $0.04 in the Year Ago Quarter and $0.05 in the Prior Quarter Demand Strengthened, Driving Another Record Backlog Entering Q1 of Fiscal 2022 Cash Balance Improved to $9.7 MillionIRVINE, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) — Lantronix, Inc. (NASDAQ: LTRX), a global provider of secure turnkey solutions for the Internet of Things (IoT) and Remote Environment...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.